CAMPIA, IVANA
CAMPIA, IVANA
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Cardiac glycosides as new modulators of cholesterol metabolism
2012-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation
2013-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1
2012-01-01 I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti
Digoxin and oubain increase the synthesis of cholesterol in human liver cells
2011-01-01 Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti
IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells
2010-01-01 I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia
Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway.
2014-01-01 P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia.
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance.
2013-01-01 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
Pleiotropic effects of liposomal nanoparticles on ABCB1 in cancer cells
2012-01-01 I. Campia ; J.Kopecka; M.L. Pinzon; D. Ghigo; C. Riganti
Targeting mevalonate pathway down-regulates ABCB1, reversing chemoresistance and immunoresistance in human cancer cells.
2012-01-01 Joanna Kopecka; Ivana Campia; Barbara Castella; Massimo Massaia; Chiara Riganti
Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells
2011-01-01 Rigoni M; Coscia M; Riganti C; Campia I; Vitale C; Peola S; Castella B; Griggio V; Pantaleoni F; Sciancalepore P; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells
2012-01-01 I. Campia; I.C. Salaroglio; J. Kopecka; M.L. Pinzòn; V. Caldera; D. Ghigo; A. Bosia; D. Schiffer; C. Riganti
The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells
2014-01-01 Candida Vitale; Valentina Griggio; Chiara Riganti; Ivana Campia; Marta Robino; Micol Rigoni; Patrizia Sciancalepore; Myriam Foglietta; Barbara Castella; Mario Boccadoro; Massimo Massaia; Marta Coscia
The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL)
2012-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Candida Vitale; Ivana Campia; Valentina Griggio; Myriam Foglietta; Barbara Castella; Patrizia Sciancalepore; Maria Elisa Canepari; Marta Robino; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells
2011-01-01 Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Valentina Griggio; Silvia Peola; Barbara Castella; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL)
2012-01-01 Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells
2012-01-01 I. Campia; J. Kopecka; B. Castella; M. Rigoni; M. Coscia; A. Bosia; D. Ghigo; M. Massaia; C. Riganti
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| Cardiac glycosides as new modulators of cholesterol metabolism | 2012 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation | 2013 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
| Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1 | 2012 | I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti | |
| Digoxin and oubain increase the synthesis of cholesterol in human liver cells | 2011 | Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti | |
| IMPACT OF THE MEVALONATE PATHWAY AND HIF/PGP AXIS IN MODULATING MULTIDRUG-RESISTANCE IN UNMUTATED CLL CELLS | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells | 2010 | I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia | |
| Mechanisms of Vgamma9Vdelta2 T cell activation by soluble metabolites generated by the mevalonate pathway. | 2014 | P. Sciancalepore; B. Castella; J. Kopecka; I. Campia; G. Gelsomino; M. Foglietta; D. Ghigo; M. Boccadoro; C. Riganti; M. Massaia. | |
| Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. | 2013 | Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo | |
| Pleiotropic effects of liposomal nanoparticles on ABCB1 in cancer cells | 2012 | I. Campia ; J.Kopecka; M.L. Pinzon; D. Ghigo; C. Riganti | |
| Targeting mevalonate pathway down-regulates ABCB1, reversing chemoresistance and immunoresistance in human cancer cells. | 2012 | Joanna Kopecka; Ivana Campia; Barbara Castella; Massimo Massaia; Chiara Riganti | |
| Targeting the mevalonate pathway and downstream signaling pathways as a strategy to circumvent multidrug-resistance in CLL cells | 2011 | Rigoni M; Coscia M; Riganti C; Campia I; Vitale C; Peola S; Castella B; Griggio V; Pantaleoni F; Sciancalepore P; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M | |
| Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells | 2012 | I. Campia; I.C. Salaroglio; J. Kopecka; M.L. Pinzòn; V. Caldera; D. Ghigo; A. Bosia; D. Schiffer; C. Riganti | |
| The Mevalonate Metabolic Pathway and the CXCL12/CXCR4 Axis Reciprocally Interact and Are Implicated in Fludarabine Resistance of Chronic Lymphocytic Leukemia Cells | 2014 | Candida Vitale; Valentina Griggio; Chiara Riganti; Ivana Campia; Marta Robino; Micol Rigoni; Patrizia Sciancalepore; Myriam Foglietta; Barbara Castella; Mario Boccadoro; Massimo Massaia; Marta Coscia | |
| The Mevalonate Pathway and Downstream Signal Transducers As Therapeutic Targets to Overcome Multidrug Resistance in Chronic Lymphocytic Leukemia (CLL) | 2012 | Marta Coscia; Micol Rigoni; Chiara Riganti; Candida Vitale; Ivana Campia; Valentina Griggio; Myriam Foglietta; Barbara Castella; Patrizia Sciancalepore; Maria Elisa Canepari; Marta Robino; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells | 2011 | Marta Coscia; Micol Rigoni; Chiara Riganti; Ivana Campia; Candida Vitale; Valentina Griggio; Silvia Peola; Barbara Castella; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| The mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL) | 2012 | Micol Rigoni; Marta Coscia; Chiara Riganti; Ivana Campia; Silvia Peola; Barbara Castella; Valentina Griggio; Francesca Pantaleoni; Patrizia Sciancalepore; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
| Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells | 2012 | I. Campia; J. Kopecka; B. Castella; M. Rigoni; M. Coscia; A. Bosia; D. Ghigo; M. Massaia; C. Riganti |